{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T11:09:19Z","timestamp":1782472159026,"version":"3.54.5"},"reference-count":35,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2021,5,3]],"date-time":"2021-05-03T00:00:00Z","timestamp":1620000000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Journal of Viral Hepatitis"],"published-print":{"date-parts":[[2021,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Background: In chronic hepatitis B (CHB) viral infection, e antigen positivity (HBeAg+) is associated with high levels of viral replication and infectivity. Furthermore, HBeAg\u2010positive CHB is associated with a liver disease spectrum ranging from none to severe. Aim: To assess whether the level of circulating HBeAg is associated with different clinical presentations of HBeAg\u2010positive CHB. Methods: A cross\u2010sectional analysis was conducted among HBV mono\u2010infected participants enrolled in Hepatitis B Research Network (HBRN) cohorts to explore clinical and virological associations with quantitative HBeAg (qHBeAg). Results: Among 763 HBeAg+ participants (56% female; 85% Asian; median age 26\u00a0years), multivariable median regression modelling significantly associated qHBeAg with liver injury (inverse qHBeAg association with ALT <jats:italic>p<\/jats:italic>&lt;.001 and APRI <jats:italic>p<\/jats:italic>&lt;.001), and with both race and age (<jats:italic>p<\/jats:italic>=0.01). Among Asians, qHBeAg was inversely related to age; a relationship less clear among Blacks and Whites. Among Asians also, median qHBeAg levels were higher among those infected with HBV genotype C versus B (<jats:italic>p<\/jats:italic>&lt;0.001), suggesting causal virologic differences. Across all races, median qHBeAg was higher in women (<jats:italic>p<\/jats:italic>=.01). Independent of sex, age, race and HBV genotype, qHBeAg was higher in participants with predominant wild\u2010type versus basal core promoter and\/or precore \u2018stop\u2019 viral variants (<jats:italic>p<\/jats:italic>&lt;0.001). Conclusion: Lower qHBeAg was observed among HBRN participants with the greatest degree of liver injury independent of demographics and HBV genotype. These data support longitudinal studies to examine the role of qHBeAg in modulating the host immune response and predicting the outcomes of chronic HBV infection.<\/jats:p>","DOI":"10.1111\/jvh.13520","type":"journal-article","created":{"date-parts":[[2021,4,24]],"date-time":"2021-04-24T07:55:55Z","timestamp":1619250955000},"page":"1042-1056","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Clinical significance of quantitative e antigen in a cohort of hepatitis B virus\u2010infected children and adults in North America"],"prefix":"10.1111","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5307-8982","authenticated-orcid":false,"given":"Stewart L.","family":"Cooper","sequence":"first","affiliation":[{"name":"UCSF Liver Center San Francisco CA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy C.","family":"King","sequence":"additional","affiliation":[{"name":"Graduate School of Public Health University of Pittsburgh Pittsburgh PA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas B.","family":"Mogul","sequence":"additional","affiliation":[{"name":"Johns Hopkins University Baltimore MD USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc G.","family":"Ghany","sequence":"additional","affiliation":[{"name":"NIDDK Bethesda MD USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen B.","family":"Schwarz","sequence":"additional","affiliation":[{"name":"Johns Hopkins University Baltimore MD USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Hepatitis B Research Network (HBRN)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2021,5,3]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.21645"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2019.1607132"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.1080\/07853890310021580"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2003.11.022"},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.1097\/MPG.0000000000002467"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2015.08.021"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2014.06.028"},{"issue":"6","key":"e_1_2_10_9_1","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1542\/peds.66.6.918","article-title":"Adolescents\u2019 self\u2010assessment of sexual maturation","volume":"66","author":"Duke PM","year":"1980","journal-title":"Pediatrics"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29542"},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2011.177741"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2009.12.052"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-137-1-200207020-00006"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2003.50346"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2893.2010.01419.x"},{"key":"e_1_2_10_16_1","unstructured":"AnnetteR PeterV HeinrichS SigridN.WHO Expert Committee on Biological Standardization (2013: Geneva Switzerland) Organization World Health. Collaborative study to establish a World Health Organization international standard for Hepatitis. B e antigen (HBeAg).2013."},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00813-10"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(89)90713-7"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.88.10.4186"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.1006\/viro.1997.8594"},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2001.22166"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21698"},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2009.107"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2010.09.012"},{"key":"e_1_2_10_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.12643"},{"key":"e_1_2_10_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.13104"},{"key":"e_1_2_10_27_1","doi-asserted-by":"publisher","DOI":"10.5812\/hepatmon.23034"},{"key":"e_1_2_10_28_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0061297"},{"key":"e_1_2_10_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/liv.12521"},{"issue":"7","key":"e_1_2_10_30_1","first-page":"866","article-title":"Relationship of HBsAg subtypes with HBeAg\/anti\u2010HBe status and chronic liver disease. Part I: Analysis of 1744 HBsAg carriers","volume":"86","author":"Shiina S","year":"1991","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_10_31_1","doi-asserted-by":"publisher","DOI":"10.1086\/314688"},{"key":"e_1_2_10_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(00)70261-7"},{"key":"e_1_2_10_33_1","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2003.50036"},{"key":"e_1_2_10_34_1","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2001.20532"},{"key":"e_1_2_10_35_1","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2002.33588"},{"key":"e_1_2_10_36_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23571"}],"container-title":["Journal of Viral Hepatitis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jvh.13520","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jvh.13520","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jvh.13520","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,30]],"date-time":"2023-08-30T17:13:42Z","timestamp":1693415622000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jvh.13520"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,3]]},"references-count":35,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["10.1111\/jvh.13520"],"URL":"https:\/\/doi.org\/10.1111\/jvh.13520","archive":["Portico"],"relation":{},"ISSN":["1352-0504","1365-2893"],"issn-type":[{"value":"1352-0504","type":"print"},{"value":"1365-2893","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,3]]},"assertion":[{"value":"2021-02-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-04-12","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-05-03","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}